Want to see TVGN full AI Analyst Report?
Total Valuation
Tevogen Bio Holdings has a market cap or net worth of $23.80M. The enterprise value is $43.31M.
Market Cap$23.80M
Enterprise Value$43.31M
Share Statistics
Tevogen Bio Holdings has 4,219,343 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding4,219,343
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Tevogen Bio Holdings’s return on equity (ROE) is 3.19 and return on invested capital (ROIC) is 3698.66%.
Return on Equity (ROE)3.19
Return on Assets (ROA)-5.99
Return on Invested Capital (ROIC)3698.66%
Return on Capital Employed (ROCE)9.73
Revenue Per Employee0.00
Profits Per Employee-1.46M
Employee Count18
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Tevogen Bio Holdings is ―. Tevogen Bio Holdings’s PEG ratio is -0.03.
PE Ratio―
PS Ratio0.00
PB Ratio-6.68
Price to Fair Value-6.68
Price to FCF-4.44
Price to Operating Cash Flow-1.55
PEG Ratio-0.03
Income Statement
In the last 12 months, Tevogen Bio Holdings had revenue of 0.00 and earned -26.28M in profits. Earnings per share was -8.08.
Revenue0.00
Gross Profit0.00
Operating Income-26.14M
Pretax Income-26.28M
Net Income-26.28M
EBITDA-25.57M
Earnings Per Share (EPS)-8.08
Cash Flow
In the last 12 months, operating cash flow was -11.75M and capital expenditures -64.43K, giving a free cash flow of -11.82M billion.
Operating Cash Flow-11.75M
Free Cash Flow-11.82M
Free Cash Flow per Share-2.80
Dividends & Yields
Tevogen Bio Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.17
52-Week Price Change-91.97%
50-Day Moving Average8.25
200-Day Moving Average15.91
Relative Strength Index (RSI)33.30
Average Volume (3m)557.82K
Important Dates
Tevogen Bio Holdings upcoming earnings date is Aug 13, 2026, Before Open (Confirmed).
Last Earnings DateJun 3, 2026
Next Earnings DateAug 13, 2026
Ex-Dividend Date―
Financial Position
Tevogen Bio Holdings as a current ratio of 0.22, with Debt / Equity ratio of -31.22%
Current Ratio0.22
Quick Ratio0.22
Debt to Market Cap0.06
Net Debt to EBITDA-0.10
Interest Coverage Ratio-133.63
Taxes
In the past 12 months, Tevogen Bio Holdings has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Tevogen Bio Holdings EV to EBITDA ratio is -2.25, with an EV/FCF ratio of -4.64.
EV to Sales0.00
EV to EBITDA-2.25
EV to Free Cash Flow-4.64
EV to Operating Cash Flow-4.67
Balance Sheet
Tevogen Bio Holdings has $692.30K in cash and marketable securities with $3.07M in debt, giving a net cash position of -$2.38M billion.
Cash & Marketable Securities$692.30K
Total Debt$3.07M
Net Cash-$2.38M
Net Cash Per Share-$0.56
Tangible Book Value Per Share-$2.48
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Tevogen Bio Holdings is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast38.95%